Actuate Therapeutics, Inc. – Indentures Watch

from S-3 39 pages Actuate Therapeutics, Inc., Issuer and [Trustee], Trustee Indenture Dated as of [], 20__ Debt Securities

from 8-K 7 pages Actuate Therapeutics, Inc. Warrant

from S-8 16 pages Actuate Therapeutics, Inc. 2024 Stock Incentive Plan Article 1 Purpose

from 10-K 3 pages Actuate Therapeutics, Inc. Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934

from S-1/A 11 pages Actuate Therapeutics, Inc. Amended and Restated Warrant

from S-1/A 12 pages Actuate Therapeutics, Inc. Second Amended and Restated Warrant

from S-1/A 16 pages Form of Representative Warrant

from S-1/A 2 pages Number Shares Countersigned: Broadridge Corporate Issuer Solutions, LLC Transfer Agent By: Authorized Signature Dated: Incorporated Under the Laws of the State of Delaware Cusip 005083 10 0 See Reverse for Certain Definitions This Certifies That: Is the Owner of C O M M on S T O C K Chief Financial Officer and Corporate Secretary President and Chief Executive Officer Fully Paid and Non-Assessable Shares of Common Stock of $0.000001 Par Value Each of Actuate Therapeutics, Inc. Transferable on the Books of the Corporation by the Holder Thereof in Person or by Duly Authorized Attorney Upon Surrender of This Certificate Duly Endorsed or Assigned. This Certificate and the Shares Represented Hereby Are Subject to the Laws of the State of Delaware, and to the Certificate of Incorporation and Bylaws of the Corporation, as Now or Hereafter Amended. This Certificate Is Not Valid Until Countersigned by the Transfer Agent. Witness the Facsimile Seal of the Corporation and the Facsimile Signatures of Its Duly Authorized Officers. Specimen Specimen Specimen - Not Negotiable Specimen Not Negotiable

from S-1 28 pages Actuate Therapeutics Inc. Fourth Amended and Restated Investor Rights Agreement

from DRS 28 pages Actuate Therapeutics Inc. Fourth Amended and Restated Investor Rights Agreement